Caranx Medical has announced the successful completion of a robotic transcatheter aortic valve implantation (TAVI) procedure in an animal.
The assisted heart valve implantation in the animal was successfully performed by the Stéphane Lopez (Institut Arnault Tzanck, Saint Laurent du var, France), alongside the company’s CMO, Eric Sejor, and CTO, Pierre Berthet-Rayne and Caranx team.
“This groundbreaking achievement is the result of hard teamwork. At Caranx Medical, we are dedicated to improving patients’ lives through true innovation. This successful transcatheter robotic aortic valve implantation marks the first step toward a new generation of intelligent robots guided by AI, set to transform healthcare as we know it,” said Berthet-Rayne, who is also a co-founder of the company.
“This major medical first lies not only in the technical achievement of Caranx Medical’s engineers, but also in the impact that this technology will have on interventional cardiology practice. By simplifying and standardising a complex procedure, the robot we have developed opens up new possibilities for improving the performance and safety of TAVI procedures,” says Sejor.
The Caranx Medical robotic solution, TAVI-PILOT, is described by the company as a simple, easy-to-use robotic solution, which promises precise, accurate and autonomous valve positioning and delivery.
